present
uniqu
inform
instanc
respiratori
syncyti
viru
rsv
infect
associ
antiphospholipid
syndrom
ap
discuss
case
context
literatur
address
immunopathogenesi
ap
associ
divers
infect
describ
case
man
signific
past
medic
histori
present
acut
onset
fever
hemoptysi
extens
bullou
ecchymot
lesion
lower
extrem
punch
biopsi
lesion
demonstr
thrombot
vasculopathi
evalu
reveal
serum
antiphospholipid
antibodi
well
posit
rsv
pcr
nasal
swab
specimen
clinic
manifest
posit
laboratori
patholog
find
strongli
suggest
ap
associ
recent
rsv
infect
infecti
etiolog
consid
ap
rsv
also
includ
differenti
diagnosi
author
publish
elsevi
ltd
open
access
articl
cc
byncnd
licens
http
present
knowledg
first
report
case
antiphospholipid
syndrom
ap
associ
respiratori
syncyti
viru
rsv
infect
ap
disord
character
vascular
thrombosi
pregnancyrel
morbid
presenc
antiphospholipid
apl
antibodi
ap
classifi
either
primari
secondari
secondari
ap
associ
autoimmun
diseas
infect
medic
malign
rsv
common
caus
agent
acut
viral
upper
lower
respiratori
tract
infect
throughout
age
group
despit
common
occurr
rsv
respiratori
infect
associ
possibl
causal
relationship
rsv
ap
knowledg
discuss
previous
report
case
progress
extens
ecchymos
appear
initi
manifest
ap
occur
tempor
associ
seemingli
trigger
recent
episod
rsv
infect
male
signific
past
medic
histori
present
month
decemb
histori
fever
maximum
temperatur
c
shake
chill
hemoptysi
worsen
dyspnea
experienc
intermitt
night
sweat
pain
swell
wrist
ankl
joint
last
sever
month
also
report
kg
weight
loss
time
never
sought
medic
attent
note
pain
ecchymot
lesion
left
calf
one
day
prior
admiss
subsequ
h
patient
develop
similar
lesion
abdomen
back
right
upper
arm
right
calf
patient
year
old
son
recent
respiratori
ill
physic
examin
patient
temperatur
c
blood
pressur
mmhg
puls
rate
beat
min
respiratori
rate
breathsmin
oxygen
satur
room
air
bilater
lung
wheez
multipl
pain
ecchymosi
sever
hemorrhag
bulla
trunk
extrem
fig
cbc
admiss
show
wbc
neutrophil
hemoglobin
gdl
comprehens
metabol
panel
includ
electrolyt
liver
renal
function
within
normal
rang
signific
laboratori
data
includ
high
lactat
dehydrogenas
iul
erythrocyt
sediment
rate
mmh
creactiv
protein
level
mgdl
xray
comput
tomographi
ct
correspond
author
present
address
azumabashi
river
pier
azumabashi
room
sumidaku
present
uniqu
inform
instanc
respiratori
syncyti
viru
rsv
infect
associ
antiphospholipid
syndrom
ap
discuss
case
context
literatur
address
immunopathogenesi
ap
associ
divers
infect
describ
case
man
signific
past
medic
histori
present
acut
onset
fever
hemoptysi
extens
bullou
ecchymot
lesion
lower
extrem
punch
biopsi
lesion
demonstr
thrombot
vasculopathi
evalu
reveal
serum
antiphospholipid
antibodi
well
posit
rsv
pcr
nasal
swab
specimen
clinic
manifest
posit
laboratori
patholog
find
strongli
suggest
ap
associ
recent
rsv
infect
infecti
etiolog
consid
ap
rsv
also
includ
differenti
diagnosi
author
publish
elsevi
ltd
open
access
articl
cc
byncnd
licens
http
present
knowledg
first
report
case
antiphospholipid
syndrom
ap
associ
respiratori
syncyti
viru
rsv
infect
ap
disord
character
vascular
thrombosi
pregnancyrel
morbid
presenc
antiphospholipid
apl
antibodi
ap
classifi
either
primari
secondari
secondari
ap
associ
autoimmun
diseas
infect
medic
malign
rsv
common
caus
agent
acut
viral
upper
lower
respiratori
tract
infect
throughout
age
group
despit
common
occurr
rsv
respiratori
infect
associ
possibl
causal
relationship
rsv
ap
knowledg
discuss
previous
report
case
progress
extens
ecchymos
appear
initi
manifest
ap
occur
tempor
associ
seemingli
trigger
recent
episod
rsv
infect
male
signific
past
medic
histori
present
month
decemb
histori
fever
maximum
temperatur
c
shake
chill
hemoptysi
worsen
dyspnea
experienc
intermitt
night
sweat
pain
swell
wrist
ankl
joint
last
sever
month
also
report
kg
weight
loss
time
never
sought
medic
attent
note
pain
ecchymot
lesion
left
calf
one
day
prior
admiss
subsequ
h
patient
develop
similar
lesion
abdomen
back
right
upper
arm
right
calf
patient
year
old
son
recent
respiratori
ill
physic
examin
patient
temperatur
c
blood
pressur
mmhg
puls
rate
beat
min
respiratori
rate
breathsmin
oxygen
satur
room
air
bilater
lung
wheez
multipl
pain
ecchymosi
sever
hemorrhag
bulla
trunk
extrem
fig
cbc
admiss
show
wbc
neutrophil
hemoglobin
gdl
comprehens
metabol
panel
includ
electrolyt
liver
renal
function
within
normal
rang
signific
laboratori
data
includ
high
lactat
dehydrogenas
iul
erythrocyt
sediment
rate
mmh
creactiv
protein
level
mgdl
xray
comput
tomographi
ct
chest
show
multifoc
alveolar
infiltr
evid
pulmonari
embol
ct
angiogram
fig
empir
treatment
intraven
ceftriaxon
oral
azithromycin
initi
commun
acquir
pneumonia
cap
ecchymos
appear
worsen
follow
day
possibl
advers
drug
reaction
rais
ceftriaxon
azithromycin
switch
levofloxacin
vancomycin
ad
second
day
admiss
punch
biopsi
ecchymot
lesion
right
arm
perform
histopatholog
find
reveal
superfici
deep
dermal
thrombot
paucicellular
vasculitisvasculopathi
involv
skin
appendag
without
signific
neutrophil
leukocytoclasia
fig
test
cryoglobulin
serum
protein
electrophoresi
spep
protein
c
protein
glycoprotein
igm
igg
rheumatoid
factor
ccp
igg
ds
dna
ab
igg
complement
level
anca
gbm
ab
igg
igg
ssa
b
ab
igg
ab
neg
test
ana
lupu
anticoagul
normal
rang
cardiolipin
ab
igm
normal
rang
phosphatidylserin
ab
igm
normal
rang
posit
nasal
swab
mrsa
sputum
respiratori
cultur
bacteria
neg
vancomycin
discontinu
fourth
day
nasopharyng
swab
influenza
antigen
streptococc
antigen
urin
legionella
antigen
neg
nasal
swab
filmarray
respiratori
panel
biofir
posit
rsv
adenoviru
coronaviru
human
metapneumoviru
rhinoviru
enteroviru
influenza
viru
parainfluenza
viru
bordetella
pertussi
chlamydophilia
pneumonia
mycoplasma
pneumonia
neg
also
possibl
infecti
etiolog
associ
ap
investig
ebv
dna
pcr
posit
copiesml
hiv
cmv
hepat
b
c
neg
patient
respiratori
symptom
gradual
improv
repeat
ct
chest
done
seventh
day
post
admiss
show
interv
improv
diffus
bibasilar
opac
transbronchi
lung
biopsi
perform
day
show
intraalveolar
hemorrhag
interstiti
fibrosi
intracapillari
megakaryocyt
lung
tissu
cultur
grew
actinomyc
odontoyiticu
staphylocc
sacchalolyticu
consid
contamin
patient
complet
cours
levofloxacin
signific
improv
respiratori
symptom
skin
lesion
also
gradual
improv
patient
improv
discharg
hospit
day
remain
good
health
subsequ
found
patient
old
son
diagnos
acut
rsv
infect
one
week
prior
patient
admiss
lupu
anticoagul
posit
normal
rang
month
discharg
probabl
associ
causal
relationship
infect
ap
well
report
variou
organ
implic
two
hit
model
propos
explain
pathogenesi
thrombosi
ap
initi
antiphospholipid
apl
antibodi
bind
endotheli
cell
promot
overproduct
tissu
factor
thromboxan
result
procoagul
state
constitut
first
hit
complement
cascad
activ
apl
antibodi
complement
system
lead
damag
endotheli
cell
result
thrombosi
process
often
potenti
presenc
inflamm
estrogen
coagulationregulatori
protein
protein
c
prothrombin
plasmin
constitut
second
hit
apl
antibodi
bind
endotheli
cell
first
step
inhibitor
usual
requir
cofactor
unit
apl
antibodi
endotheli
cell
certain
infect
molecul
infecti
agent
epitop
known
structur
sequenti
similar
molecular
similar
consid
key
mechan
ap
associ
infect
hepat
c
viru
hcv
epsteinbarr
viru
ebv
varicella
viru
parvoviru
cytomegaloviru
cmv
human
immunodefici
viru
hiv
adenoviru
virus
associ
ap
circul
contrast
sene
cowork
suggest
viral
infect
bacteri
infect
may
associ
posit
anticardiolipin
antibodi
acl
associ
anti
seen
case
filmarray
respiratori
panel
biofir
new
molecular
test
use
assess
respons
panel
respiratori
virus
bacteria
result
avail
sever
hour
sensit
specif
report
respect
patient
test
rsv
posit
test
infecti
etiolog
previous
associ
ap
neg
except
ebv
although
acut
ebv
infect
associ
ap
previou
case
report
lack
cervic
lymphadenopathi
hepatosplenomegali
neg
anti
made
acut
ebv
infect
less
like
case
addit
recent
retrospect
studi
found
preval
apl
among
patient
acut
ebv
none
apl
symptom
ap
apl
resolv
test
plausibl
howev
within
twohit
model
patient
may
condit
associ
apl
antibodi
instanc
ebv
condit
could
account
patient
preced
symptom
fever
weight
loss
arthralgia
etc
sever
month
prior
rsv
rsv
serv
inflammatori
trigger
induc
symptom
ap
presenc
multipl
ecchymos
unexplain
intermitt
fever
joint
swell
weight
loss
sever
month
led
consider
rheumatolog
diseas
rheumatoid
arthriti
vascul
specif
system
lupu
erythematosu
sle
american
colleg
rheumatolog
recommend
propos
criteria
present
identifi
patient
sle
howev
patient
meet
diagnost
criteria
diseas
met
two
criteria
slea
posit
immunolog
disord
posit
antinuclear
antibodi
instead
posit
lupu
anticoagul
normal
rang
cardiolipin
ab
igm
normal
rang
repeat
month
discharg
hospit
support
diagnosi
ap
summari
develop
ecchymot
lesion
follow
recent
respiratori
infect
patholog
confirm
thrombot
vasculopathi
skin
biopsi
posit
acl
igm
phosphatidylserin
ab
igm
posit
rsv
molecular
test
strongli
suggest
ap
associ
recent
rsv
infect
without
prior
sensit
exposur
rsv
also
includ
differenti
diagnosi
infecti
etiolog
ap
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
none
inform
consent
obtain
patient
